2008 Minority Scholars

	Irene Alvarez, B.S., University of Arizona, Tucson, AZ. Abstract # 3133. Effects of green tea polyphenols on UV-induced lipid peroxidation in skin cell models
	Tunde O. Akinyeke, B.S., Meharry Medical College, Nashville, TN. Abstract # 3316. Troglitazone reduces c-Myc protein expression in the C4-2 human prostate cancer cell line
	Melissa Baralt, M.A., University of Medicine and Dentistry of NJ, Newark, NJ. Abstract # 5781. The interaction of nonerythroid alpha spectrin with DNA containing interstrand cross-links.
	Federico Bernal, Ph.D., Dana-Farber Cancer Institute, Boston, MA. Abstract # 2548. A stapled p53 helix targets both HDM2 and HDMX to restore p53 activity in human cancer
	Cristina M. Contreras, B.S., UT Southwestern Medical Center, Dallas, TX.
	Wilfredo E. De Jesus-Monge, M.S., University of Puerto Rico, San Juan, PR.
	Chris R. Evelyn, B.S., University of Michigan, Ann Arbor, MI. Abstract # 4776. Structure activity relationship study of CCG-1423, an inhibitor of Rho/MKL1-stimulated gene transcription
	Vivian A. Galacia, B.S., University of Southern California, Los Angeles, CA. Abstract # 4566. The role of the AMPK energy sensing pathway in Pten-deletion induced liver carcinogenesis in vivo
	Olguitza Y. Guzman, B.S., University of North Carolina, Chapel Hill, NC. Abstract # 2920. A genetically-engineered mouse model of glioblastoma for targeted drug-biomarker co-development
	Djuana M.E. Harvell, Ph.D., University of Colorado Health Sciences Center, Aurora, CO. Abstract # 4493. Estrogen-regulated gene expression following neoadjuvant hormone therapy of breast cancers: dominance of tamoxifen agonist effects in the presence of an aromatase inhibitor
	Dawn M. Holt, M.S., University of Maryland, Baltimore, MD. Abstract # 4645. Decreased COX-2 pathway metabolism and EP receptor signaling modulates Natural Killer cell activities
	Pamela R. Jackson, B.S., University of California, San Francisco, CA. Abstract # 4537. Multiexponential MR ADC and T2 of astrocytoma cells in agar
	Darnell T. Josiah, M.S., Wakeforest University School of Medicine, Winston-Salem, NC. Abstract # 4613. Oncolytic virus therapy for glioblastoma multiforme delivered by adipose-derived mesenchymal stem cells
	Stacey A. Kenfield, Sc.D., Channing Laboratory, Brigham and Women's Hospital, Boston, MA. Abstract # 4166. A prospective study of Mediterranean diet and risk of prostate cancer
	Nicole A. Lavendar, B.S., University of Louisville, Louisville, KY. Abstract # 1881. Influence of high order interactions between variant DNA repair genes on prostate cancer risk in African-American men
	Alrena V. Lightbourn, M.S., Florida A&M University, Tallahassee, FL. Abstract # 2258. Fig (Ficus carica) leaf extract prevents diethylstilbestrol (DES)-induced DNA strand breaks in single-cell gel electrophoresis (SCGE)/COMET assay
	John T. McDonald, B.S., University of California, Los Angeles, CA. Abstract # 4823. Nrf2 inducers can modify the radiation response
	Rene Nieves-Alicea, Ph.D., UT MD Anderson Cancer Center, Houston, TX. Abstract # 3676. Programmed Cell Death 4, a potential novel suppressor of breast cancer bone metastasis
	Sarah J. Nyante, M.S.P.H., University of North Carolina, Chapel Hill, NC. Abstract # 5811. Single nucleotide polymorphisms in relation to basal-like and luminal A intrinsic breast cancer subtypes in African Americans and whites
	Yanique Rattigan, B.S., University of Medicine and Dentistry of New Jersey, New Brunswick, NJ. Abstract # 2056. Migration of mesenchymal stem cells to tumor cells under hypoxia
	Benjamin A.T. Rodriguez, B.A., The Ohio State University, Columbus, OH. Abstract # 17. Estrogen represses transcription of epigenetically reactivated genes in breast cancer cells
	Jessica M. Silva, B.S., Mayo Clinic Graduate School, Rochester, MN. Abstract # 5051. A new class of novel long highly conserved Non-Coding Transcripts (hcNCTs) are altered in cancer
	Christopher Sistrunk, M.A., North Carolina State University, Raleigh, NC.
	Gabriel J. Villares, B.S., UT MD Anderson Cancer Center, Houston, TX. Abstract # 339. Gene expression profile of PAR-1 depleted human melanoma cells identifies Connexin 43 as a target influencing growth and metastasis